Svec Jiří, Schwarzová Lucie, Janošíková Bohumila, Stekrová Jitka, Mandys Václav, Kment Milan, Vodička Pavel
2nd Department of Internal Medicine, 3rd Faculty of Medicine, Charles University Prague ; Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic Prague.
Institute of Biology and Medical Genetics, 1st Faculty of Medicine and General Teaching Hospital, Charles University Prague.
Int J Clin Exp Pathol. 2014 Jul 15;7(8):5196-202. eCollection 2014.
Muir-Torre syndrome (MTS), a rare variant of the hereditary non polyposis colorectal cancer syndrome, is an autosomal dominant genodermatosis characterised by coincidence of sebaceous gland neoplasms (sebaceous adenoma, epithelioma, or carcinoma) and at least one internal malignancy. The underlying cause of MTS is a germline mutation in DNA mismatch repair genes MSH2, MLH1 and MSH6. We report the case of a 52-year-old caucasian woman with the development of metachronous colon cancer at the age of 38 years, uterine cancer at the age of 43 years, and unique occurrence of synchronous gastric and sebaceous carcinomas related to germline point mutation c. 2194A>T in the last exon of MLH1 gene, resulting in truncated protein in C-terminal region p. Lys732X due to premature stop codon. This mutation, not previously reported in MTS, disrupts the function of MutL complexes presumably by preventing the interaction with PMS1/PMS2 and impairing the endonuclease active site. This case points out the importance of sebaceous neoplasia, especially sebaceous adenocarcinoma, as cutaneous markers of MTS for timely implementation of cancer screening programs.
穆尔-托雷综合征(MTS)是遗传性非息肉病性结直肠癌综合征的一种罕见变体,是一种常染色体显性遗传性皮肤病,其特征是皮脂腺肿瘤(皮脂腺腺瘤、上皮瘤或癌)与至少一种内部恶性肿瘤同时存在。MTS的根本原因是DNA错配修复基因MSH2、MLH1和MSH6中的种系突变。我们报告了一例52岁的白种女性病例,该患者38岁时发生异时性结肠癌,43岁时发生子宫癌,且因MLH1基因最后一个外显子中的种系点突变c.2194A>T,导致在C末端区域p.Lys732X处出现截短蛋白,出现了罕见的同步性胃癌和皮脂腺癌。这种突变此前在MTS中未被报道,可能通过阻止与PMS1/PMS2的相互作用并损害内切核酸酶活性位点,破坏了MutL复合物的功能。该病例指出了皮脂腺肿瘤,尤其是皮脂腺腺癌,作为MTS皮肤标志物对于及时实施癌症筛查计划的重要性。